Brief: HLS Therapeutics Announces Q1 Fiscal 2022 Financial Results
05/05/2022 12:59
May 5 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES Q1 FISCAL 2022 FINANCIAL
RESULTS
* Q1 LOSS PER SHARE $0.11
* Q1 REVENUE $14.6 MILLION VERSUS $14.3 MILLION
* Q1 EARNINGS PER SHARE VIEW $-0.10, REVENUE VIEW $15.6
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nCNWt5S8Qa
Further company coverage: HLS.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group